Skip to Content

UPMC Children’s Hepatology Faculty Presenting at AASLD and AHA Annual Meetings

September 26, 2022

Check out these upcoming lectures and abstract presentations from faculty in the UPMC Children’s Hospital of Pittsburgh Hepatology Program. We hope to see colleagues and friends at this year’s AASLD Liver Meeting and the American Heart Association Annual Meeting.

AASLD – The Liver Meeting

November 4-8, 2022 in Washington, D.C.

Presentation Title: Accuracy of GDF15 and FGF21 to Differentiate Mitochondrial Hepatopathies from Other Pediatric Liver Diseases.

Authors: Ronald J. Sokol, Marisa W. Friederich, Dana K. Strode, Roxanne A. Van Hove, Kristen Miller, Linda Gabel, Simon Horslen, Rohit Kohli, Mark Lovell, Alex Miethke, Jean Molleston, Rene Romero, James Squires, Robert Squires, Shikha S. Sundaram, John Magee, Johan L.K. Van Hove, on behalf of the Childhood Liver Disease Research Network (ChiLDReN).

Presentation Title: Barriers to Identifying and Intervening on Social Needs in Pediatric Liver Transplantation: Qualitative Results From the Multi-center Social & Contextual Impact on Children Undergoing Liver Transplantation (SOCIAL-Tx) Study.

Authors: Sharad I. Wadhwani, MD MPH; Alejandra Alvarado, MA; Holly Shifman, MS; James Squires, MD MS; Kathleen Campbell, MD; Noelle Ebel, MD; Evelyn Hsu, MD; Jennifer Vittorio, MD; Shannon Zielsdorf, MD; Dev Desai, MD; Nitika Gupta, MBBS; John C. Bucuvalas, MD; Laura Gottlieb MD, MPH; Uma Kotagal, MBBS; Courtney R. Lyles, PhD; Jennifer C. Lai, MD MBA.

Presentation Title: The Plasma Proteome in Pediatric Cholestasis Reveals Biomarkers of Liver Stiffness and Suggests a Role for Epithelial-To-Mesenchymal Transition in Fibrogenesis

Authors: Shneider BL, Kanchi R, Gromm SL, Schraw JM, Bezerra JA, Loomes KM, Magee JC, Sokol RJ, Wang KS, Alonso EM, Hsu EK, Molleston JP, Rosenthal P, Karpen SJ, Horslen SP, Jensen MK, Kamath BM,Lupo PJ, Coarfa C and the Childhood Liver Disease Research Network (ChiLDReN).

Presentation Title: Safety and Tolerability characterization of Maralixibat in Infants with ALGS from 2 months of age: Interim Results from the RISE study

Authors: Gonzales E, Jankowska I, Horslen SP, Ekong U, Rosenthal P, Sokal E, Lin C-H, Garner W, Elliott J, Nunes T, Thompson RJ.

Presentation Title: Efficacy and Safety of Maralixibat in Patients with Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC): A Randomized Placebo-Controlled Phase 3 Study

Authors: Miethke A, Moukarzel A, Porta G, Covarrubias Esquer J, Czubkowski P, Ordonez F, Candusso M, Aqul AA, Squires RH, Sokal E, D’Agostino D, Baumann U, D’Antiga L, Kasi N, Laborde N, Arikan C, Lin C-H, Gilmour S, Mittal N, Chiou FK, Horslen SP, Huber W-D, Van Leerberghe A, Weber Ronn S, Nunes T, Lascau A, Longpre L, Garner W, Vig P, Hupertz VF, Gonzalez-Peralta RP, Ekong U, Hartley J, Laverdure N, Ovchinsky N, Thompson RJ.

American Heart Association Annual Meeting

November 5-7, 2022 in Chicago, Illinois.

Presentation Title: Cardiac Magnetic Resonance Imaging Derived Inferior Vena Cava Cross-sectional Area Correlates with Measures of Fontan Associated Liver Disease.  

First Author: Megan Gunsaulus. Co-authors: Veena Venkat and Simon Horslen.

Abstract #11739.